TORONTO, ONTARIO and LONDON, ONTARIO--(Marketwire - Feb 28, 2013) - The Centre for Commercialization of Regenerative Medicine (CCRM) is pleased to announce the addition of Sernova Corp. ("Sernova" or the "Company") (TSX VENTURE:SVA) to its member-based industry consortium. Sernova''s combination of immuno-protective technology and therapeutic cells for the treatment of chronic diseases advances CCRM''s goal of developing innovative cell-based product.

"Sernova''s technology for transplanting therapeutic cells into an implanted medical device for the treatment of diabetes and other chronic diseases goes hand-in-hand with our strategy of translating cell-based medical discoveries into commercial products and therapies," says Dr. Michael May, CEO of CCRM. "Sernova''s expertise in the area of cell therapy will bring great value to CCRM''s core development platforms and to other consortium members."

CCRM is working with its industry consortium to address real-life bottlenecks in cell-based product pipelines. Its industry consortium now numbers over 20 members. These companies represent the key sectors of the industry: therapeutics, devices, reagents, and cells as tools.

"Becoming a member of CCRM offers the opportunity for further validation for our technology and demonstrates our company''s commitment to the advancement of our Cell Pouch System as an effective, safe, long-term and convenient therapeutic option for the treatment of chronic diseases," says Dr. Philip Toleikis, President and CEO of Sernova Corp. "We will work together with the other consortium members to achieve CCRM''s objectives in treating and managing devastating diseases such as diabetes."

CCRM has built three core development platforms:cell reprogramming and engineering; cell manufacturing; and, biomaterials and devices to carry out projects commissioned by academia and industry. CCRM has a fully resourced, 6,000 square foot development facility where all development work takes place.

Please visit http://www.ccrm.ca/industry-consortium to see a complete list of CCRM''s members.

About the Centre for Commercialization of Regenerative Medicine (CCRM)

CCRM, a Canadian not-for-profit organization funded by the Government of Canada''s Networks of Centres of Excellence program and six academic partners, supports the development of technologies that accelerate the commercialization of stem cell- and biomaterials-based technologies and therapies. A network of academics, industry and entrepreneurs, CCRM aims to translate scientific discoveries into marketable products for patients. CCRM launched in Toronto''s Discovery District on June 14, 2011.

About Sernova

Sernova Corp. is a clinical stage health-sciences company focused on commercializing medical technologies. Sernova is currently developing a platform technology for a number of serious disease indications, starting with a novel treatment for insulin-dependent diabetes, using the novel Cell Pouch System for transplantation and long-term survival of therapeutic cells and its patented Sertolin cell technology, which can provide an immune-protected local environment for therapeutic cells.

Follow this link:

Sernova and Centre for Commercialization of Regenerative Medicine Partner to Treat Chronic Diseases

DUBAI, United Arab Emirates, Feb. 28, 2013 /PRNewswire/ -- We may have Siri in our iPhones, and may soon be driving smart cars running on algorithms, but we still drink bitter medicine today the way we used to a century ago. Most people simply take liquid medicine with water or sugared drinks to quickly get rid of the bitterness. That may not be the case anymore, thanks to Tongue Cover, the first product to solve the problem of bitter medicines not by masking or diluting them, but by blocking the taste altogether.

"This is going to forever change the way we take medicine," says Haris, the inventor, who spent a year planning and prototyping the Tongue Cover after completing an MBA in International Business in Phoenix, AZ. The product acts as a latex protective barrier, forming a sheath over the tongue, thereby blocking and protecting the tongue from the bitter taste of liquid medicines, health drinks, herbal teas, vitamin solutions or pills. "Pharmaceutical companies have long focused on sugar-coating pills or diluting liquid medicines to make them more bearable," he says, "but I envision the Tongue Cover to be the standard with every bottle of medicine in a couple of years from now."

That vision has already found support in some scientific quarters. Former Advisor to WHO for Eastern Mediterranean Region, Dr. Mohammad Waseem-ul-Islam, is a believer. "What motivates me to support this product is the scope of its potential social impact," he says. "This could fundamentally change the way 7 billion people take medicine, and everybody falls sick at some point. This is not just a particular demographic segment of society we're talking about. This would be about everybody; this is for everybody."

Crowdfunding

The patent-pending product is now available for pre-order on Indiegogo, the international crowdfunding website. The site, similar to Kickstarter, is known to have funded some of the most creative and edgy inventions in the recent past.

As is the fast-growing trend these days, venture capitalists and angel investors were largely ignored. "I want to put this product directly in people's hands, be it patients, doctors or distributors, so they can try it for themselves while helping us grow, developing its commercial appeal and keeping costs low," he says. "We are ideally looking to raise $125,000 for our first production run to achieve true economies of scale."

Pre-orders range from $1 for a single Tongue Cover sample to large wholesale packages. For more information or to place a pre-order, go to http://www.indiegogo.com/Tongue-Cover.

Contact details: Haris Ayoubi tonguecover@gmail.com +1 (623) 565-8473 +971 (55) 822-7356 XA 04, Jebel Ali Freezone Dubai, U.A.E. 17305

Links: http://www.indiegogo.com/Tongue-Cover http://www.tonguecover.com

Notes to Editors:

See the rest here:

Tongue Cover Blocks Bitter Taste to Help the Medicine Go Down

YOUNGSTOWN, OH--(Marketwire - February 28, 2013) - Avalon University School of Medicine (AUSOM) is a growing leader in medical education. Avalon University School of Medicine focuses on quality medical education and training in order to ensure medical licensure and residency placement for international medical students and graduates.Avalon University School of Medicine is situated on Curacao; which is a highly developed and safe country with a supportive and pro-education government.Avalon University offers programs in Pre-Medicine, Doctor of Medicine and Clinical Sciences. Avalon University's curriculum is designed to prepare medical students for the United States Medical Licensing Exam (USMLE) exams.

"A recent Graduate Of Avalon University has this to say"

"Hi. My name is Dr. Carolyn Sok and I am a graduate of Avalon University School of Medicine. I am currently completing residency in Pathology at Metro Health, one of Cleveland's top trauma centers. It has been my experiencethat the education that I received at Avalon has thoroughly prepared me for a career in the competitive field of medicine.I was able to complete Basic Sciences in Curacao in only 16 months away from home, and then I was able to return to the United States to complete clinical rotations in ACGME green book teaching hospitals.I completed rotations right alongside US medical students.

"The education at Avalon University is top notch -- it has prepared me for the most important exams, the USMLE I, and it also provided me with clinical exposure to make me a more competitive candidate for securing a US residency position.

"For me personally, the faculty at Avalon made all the difference!The education was personal and they made sure that I understood the material being taught. As nervous as I was to enter medical school, Avalon made it very personal, comfortable and provided all the necessary tools to become a successful US practicing physician.

"Choosing a career in medicine is very challenging, but more important is choosing the right medical school. My decision to attend Avalon was one of the best decisions I have ever made.It not only made my dreams come true, but also fulfilled the dreams of my family as well."

For more information about AUSOM top Caribbean medical school, visit the AUSOM website.

Read the original:

USA Today Exciting Feature on Quality Medical Education at Avalon University School of Medicine

BG Medicine announced the publication of two studies demonstrating the clinical utility of repeated galectin-3 testing as a tool in the assessment of patients with heart failure. The studies, which together involved more than 3,300 subjects, demonstrate that periodic evaluation of galectin-3 levels can help clinicians identify those at greater risk of unplanned hospital admission and cardiovascular morbidity and mortality. The first study, published online ahead of print in the current issue of Circulation Heart Failure, demonstrated that patients who experienced increases in their galectin-3 levels in excess of 15% over a period of three to six months had nearly double the risk of subsequent unplanned hospital admissions and mortality relative to patients who did not experience changes in their galectin-3 levels over the same time period. This increased risk was found to be independent of other important risk factors in heart failure, including cardiac function, renal function, age, and levels of NT-proBNP. The second study, published online ahead of print in the European Journal of Heart Failure, demonstrated that patients who experienced increases in galectin-3 levels over a period of four months were at significantly increased risk of subsequent unplanned hospital admissions for heart failure, first morbid event, and mortality. The increased risk associated with elevations in galectin-3 was found to be independent of all other baseline heart failure risk factors considered. Importantly, this increased risk associated with galectin-3 elevation was also demonstrated to be independent of, and additive to, concomitant changes in other important heart failure risk factors, including cardiac structure, renal function, blood pressure, heart rate, NT-proBNP levels, and other clinical patient parameters.

Originally posted here:

BG Medicine publishes 2 studies supporting repeat Galectin-3 testing

WALTHAM, Mass., Feb. 27, 2013 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (BGMD), a diagnostics company focused on the development and commercialization of novel cardiovascular tests, announced today the publication of two studies demonstrating the clinical utility of repeated galectin-3 testing as a tool in the assessment of patients with heart failure. The studies, which together involved more than 3,300 subjects, demonstrate that periodic evaluation of galectin-3 levels can help clinicians identify those at greater risk of unplanned hospital admission and cardiovascular morbidity and mortality.

The first study, published online ahead of print in the current issue of Circulation Heart Failure [1], demonstrated that patients who experienced increases in their galectin-3 levels in excess of 15% over a period of three to six months had nearly double the risk of subsequent unplanned hospital admissions and mortality relative to patients who did not experience changes in their galectin-3 levels over the same time period. This increased risk was found to be independent of other important risk factors in heart failure, including cardiac function, renal function, age, and levels of NT-proBNP.

The second study, published online ahead of print in the European Journal of Heart Failure [2], demonstrated that patients who experienced increases in galectin-3 levels over a period of four months were at significantly increased risk of subsequent unplanned hospital admissions for heart failure, first morbid event, and mortality. The increased risk associated with elevations in galectin-3 was found to be independent of all other baseline heart failure risk factors considered. Importantly, this increased risk associated with galectin-3 elevation was also demonstrated to be independent of, and additive to, concomitant changes in other important heart failure risk factors, including cardiac structure, renal function, blood pressure, heart rate, NT-proBNP levels, and other clinical patient parameters.

"We are very encouraged by these published results, which add to the growing body of evidence supporting the repeated use of galectin-3 testing as an ongoing monitoring tool in the management of patients with heart failure," said Eric Bouvier, President and CEO of BG Medicine. "We believe these findings validate our commercial focus on the use of galectin-3 testing to combat unplanned hospital readmissions, and will help us drive further clinical adoption of galectin-3 testing as a routine part of heart failure management."

The BGM Galectin-3(R) Test is cleared by the FDA as an aid in assessing the prognosis of patients with chronic heart failure, to be used in conjunction with clinical evaluation.

About Galectin-3 and Heart Failure

Galectin-3 is a unique carbohydrate-binding lectin, or protein, that binds to carbohydrates called beta-galactosides. Galectin-3 has been implicated in a variety of biological processes important in the development and progression of heart failure, and is believed to be a primary mediator of progressive cardiac fibrosis (abnormal thickening and stiffening of the heart muscle) and adverse remodeling (changes in the structure of the heart). Higher levels of galectin-3 are associated with a more aggressive form of heart failure and 30% or more of mild to moderate heart failure patients will have elevated levels of galectin-3. Heart failure affects an estimated 5.7 million Americans, with approximately 670,000 new cases occurring each year. The direct and indirect cost of heart failure in the United States for 2011 is estimated to be $34.4 billion [3,4].

About BG Medicine, Inc.

BG Medicine, Inc. (BGMD) is a diagnostics company focused on the development and commercialization of novel cardiovascular tests to address significant unmet medical needs, improve patient outcomes and reduce healthcare costs. The Company has two products: the BGM Galectin-3(R) test for use in patients with chronic heart failure is available in the United States and Europe; and the CardioSCORE(TM) test for the risk prediction of major cardiovascular events will be launched in Europe in the first half of 2013. For additional information about BG Medicine, heart failure and galectin-3 testing, please visit http://www.bg-medicine.com and http://www.galectin-3.com.

The BG Medicine Inc. logo is available at the following link: http://www.globenewswire.com/newsroom/prs/?pkgid=10352.

Excerpt from:

BG Medicine, Inc. Announces Publication of Two Studies Supporting Repeat Galectin-3 Testing in Heart Failure Patients

WALTHAM, Mass., Feb. 27, 2013 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (BGMD) ), a company focused on the development and commercialization of novel cardiovascular diagnostics, announced today that Eric Bouvier, BG Medicine's President and CEO, will be presenting at the Cowen and Company 33rd Annual Health Care Conference on March 4, 2013, at the Boston Marriott Copley Place, beginning at 2:10 PM Eastern Time (ET).

Audio and slides of BG Medicine's presentation will be webcast at: http://wsw.com/webcast/cowen10/bgmd/.

The webcast will be archived for 30 days following the live presentation on BG Medicine's Investor Relations website at ir.BG-medicine.com.

About BG Medicine

BG Medicine, Inc. (BGMD) is a diagnostics company focused on the development and commercialization of novel cardiovascular tests to address significant unmet medical needs, improve patient outcomes and reduce healthcare costs. The Company has two products: the BGM Galectin-3(R) test for use in patients with chronic heart failure is available in the United States and Europe; and the CardioSCORE(TM) test for the risk prediction of major cardiovascular events will be launched in Europe in the first half of 2013. For additional information about BG Medicine, heart failure and galectin-3 testing, please visit http://www.bg-medicine.com and http://www.galectin-3.com.

The BG Medicine Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=10352.

More here:

BG Medicine, Inc. to Present at Cowen and Company 33rd Annual Health Care Conference

50 LB. Medicine Ball Drops EQBC
It #39;s not that high, but it #39;s still no joke. Christian is 138 lbs.

By: ShootaFairOne

Here is the original post:

50 LB. Medicine Ball Drops EQBC - Video

Communicating about Science, Health and Medicine: Can it Really be that Difficult?
Dr. Glen Nowak, director of News and Electronic Media at the Centers for Disease Control and Prevention Learn how the nation #39;s largest health organization communicates with its audiences. Dr. Nowak is the director of News and Electronic Media at the Centers for Disease Control and Prevention. He serves as the senior media advisor to the CDC director and senior agency managers and also manages CDC #39;s Division of News and Electronic Media. Dr. Nowak has developed and implemented media relations strategies related to the 2009 H1N1 pandemic, numerous multi-state foodborne disease outbreaks, HIV/AIDS prevention, obesity, tobacco and smoking, childhood and adult immunization, and new/emerging diseases. He has also helped guide CDC #39;s electronic and social media efforts. In 2009, CDC #39;s media relations group was the first place winner in the PR News Non-Profit Awards Crisis Management category for "CDC Responds to 2009 H1N1 Influenza." Prior to joining the Office of Media Relations in 2004, Dr. Nowak served as the associate director for communications at the National Immunization Program at the CDC. He served as NIP #39;s first director of communications, responsible for creating and managing what ultimately became a 20-person communications group responsible for media relations, risk communications, immunization promotion, graphics and creative services, communication research and NIP #39;s website. Before he joined the CDC in January 1999, Dr. Nowak was an associate professor of ...

By: CMCISatUSC

Read the rest here:

Communicating about Science, Health and Medicine: Can it Really be that Difficult? - Video

20th Annual Drexel University College of Medicine Pediatric AIDS Benefit Concert
The annual Drexel University College of Medicine Pediatric AIDS Benefit Concert was a wonderful, fun-filled evening that raised $27500 for children with HIV and AIDS. More than 420 students, faculty and guests sang, danced, and laughed their way through the February 18th event that showcased a total of 14 acts. Clip courtesy of 6 ABC. Thanks for coming to cover the event!

By: DrexelMedicine

More here:

20th Annual Drexel University College of Medicine Pediatric AIDS Benefit Concert - Video

Michael E. Zenilman, MD, Professor of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, and Director, National Capital Region, Johns Hopkins Medicine, Bethesda, MD, presented on Surgical Concerns: Geriatric Syndromes, and William B. Greenough III, MD, Professor of Medicine, Johns Hopkins University School of Medicine, presented an Update on Wound Care, at the 57th Annual Philip A. Tumulty Topics in Clinical Medicine, presented by Johns Hopkins University School of Medicine.

Glendale, CA (PRWEB) February 25, 2013

The goal of this program is to improve management of elderly patients undergoing surgery, wound care, and care for diabetes. After hearing and assimilating this program, the clinician will be better able to:

1. Predict surgical risk based on comorbidities and geriatric syndromes.

2. Perform specific tests to assess preoperative frailty.

3. Select and effectively apply appropriate dressings to assist wound healing.

4. Use effective antibacterial agents to minimize infection in pressure sores.

5. Weigh evidence about the effects of medications for tight glycemic control, and about the effects of tight control on outcomes.

The original programs were presented by Robert A. Wiebe, MD, Clinical Professor, Pediatric Emergency Medicine, University of Texas Southwestern Medical Center, Dallas, and Lalit Bajaj, MD, MPH, Associate Professor of Pediatrics, University of Colorado School of Medicine, and Research Director, Section of Emergency Medicine, Childrens Hospital, Denver.

Audio-Digest Foundation, the largest independent publisher of Continuing Medical Education in the world, records over 10,000 hours of lectures every year in anesthesiology, emergency medicine, family practice, gastroenterology, general surgery, internal medicine, neurology, obstetrics/gynecology, oncology, ophthalmology, orthopaedics, otolaryngology, pediatrics, psychology, and urology, by the leading medical researchers at the top laboratories, universities, and institutions.

See the original post here:

Audio-Digest Foundation Announces the Release of Family Medicine Volume 61, Issue 01: Guidelines in Geriatric Care

BILLERICA, Mass.--(BUSINESS WIRE)--

With a range of products and services driving the development of personalized medicine, Aushon Biosystems has appointed Thomas Mac Mahon, former president and CEO of Laboratory Corporation of America Holdings (LabCorp), to its board of directors. The expansion of its board builds on Aushons recent momentum as it is poised for significant growth in 2013.

Aushon provides a suite of multiplex immunoassay products and services for the discovery and development of the biomarkers necessary to enable personalized medicine innovation. Aushons multiplex approach involves simultaneously measuring and comparing multiple proteins which eliminates the cost and time obstacles that have traditionally been associated with personalized medicine development with the singleplex ELISA platform.

Multiplex technology allows us to cast a wider net across a diverse array of biologies known to play a role in the development of cancer and determine the response of pharmacological agents on them, saidDr. Andrew Nixon, associate professor of medicine and director of the Phase I Biomarker Laboratory at Duke University. Using this research approach, were better able to allocate our limited resources both patient sample and money for optimal success.

Life sciences and diagnostics industry veteran Mac Mahon took notice of Aushons multiplex approach as critical to the future of personalized medicine.

The current gold-standard approach to protein analysis comes with unnecessary cost and time barriers that prevent personalized medicine from becoming a reality for all, said Mac Mahon. Im excited to continue my work advancing diagnostics and personalized medicine advancement with Aushon which has created the approach that breaks down the current barriers and will drive the future of personalized medicine.

Mac Mahon served as chairman of LabCorp from 1996 to 2009 and as CEO and president from 1997 to 2006. Previously, he held the roles of senior vice president of Hoffmann-La Roche Inc., president of Roche Diagnostics Group, and chairman of PharMerica Corporation. Mac Mahon has also been presiding director of Aristotle Holding, Inc. and Express Scripts Holding Company since May 2008 and also serves as a director of SynapDx Corporation.

Aushon Poised for Continued Growth

With key areas of expertise in oncology and inflammatory diseases, Aushon now works with nine out of the top 10 pharmaceutical companies and is expecting more than 30 percent year-over-year revenue growth this year. To support this growth and anticipated doubling of revenue in 2014, Aushon also plans to increase its employee base by 25 percent in 2013. In addition, Aushon will expand its global footprint, with current employees and distributors across North America, Europe, Asia and Australia.

Ultimately, personalized medicine will bring better treatments at lower costs to the average patient. This can only happen if we empower discovery through accurate, time- and cost-effective means, said Pete Honkanen, CEO, Aushon. Tom is an invaluable resource to Aushon as we continue to drive transformation in the industry.

Read more:

Aushon Biosystems Thrives with Increasing Demand for Personalized Medicine

BOCA RATON, FL--(Marketwire - Feb 25, 2013) - Modernizing Medicine, the creator of the Electronic Medical Assistant (EMA), a cloud-based specialty-specific electronic medical record (EMR) system, announced today that it has been listed as No. 2 on the South Florida Business Journal's annual Best Places to Work list. This list highlights companies in Palm Beach, Broward and Miami-Dade counties whose operations are changing the business landscape in South Florida.

"We are very excited to be named one of the best places to work by the South Florida Business Journal," said Daniel Cane, Modernizing Medicine's President and CEO. "The best part of receiving this award is that it was determined by our employees who are truly the backbone of Modernizing Medicine. Together we've been able to create revolutionary products that are improving the way doctors practice medicine and changing the medical industry for the better -- and to be able to say that we have had a lot of fun doing it, that's just the cherry on top."

The South Florida Business Journal's Best Places to Work list features winners in three categories: Small (10-50 employees), Medium (51-149 employees) and Large (150+ employees). With 126 employees, Modernizing Medicine secured its place on the Medium list. In order to determine the winners of each category, the South Florida Business Journal distributed a survey to employees of the various companies, asking questions about how they felt about their company's culture, career advancement opportunities and the overall working environment. From there, the South Florida Business Journal narrowed the field down to a list of finalists, announcing the winners at a luncheon on February 21, 2013.

Modernizing Medicine's inclusion on the South Florida Business Journal's Best Places to Work list comes shortly after it was named one of FORBES' America's Most Promising Companies, exemplifying its growth not only as a leader in the EMR space but also as a nationally recognized business leader. Over the past year Modernizing Medicine has grown its customer base to over 2,000 providers, more than doubled its staff, grew its product line with the addition of EMA Plastic Surgery and closed a $12 million dollar capital raise, with a combination of equity capital and a senior debt bank facility. The growing team enjoyed company happy hours, holiday parties and outings along the way, helping to develop and foster Modernizing Medicine's culture, truly making it a wonderful place to work.

Modernizing Medicine is looking forward to an exciting year, with the launch of EMA Cosmetic, EMA Orthopedics and EMA Otolaryngology.

About Modernizing MedicineModernizing Medicine is delivering the next generation of electronic medical records (EMR) technology for the healthcare industry. Our product, Electronic Medical Assistant (EMA), is a cloud-based specialty-specific EMR with a massive library of built-in medical content, designed to save physicians time. Available as a native iPad application or from any web-enabled Mac or PC, EMA adapts to each provider's unique style of practice and is designed to interface with over 400 different practice management systems. Today, Modernizing Medicine provides specialty-specific offerings for the dermatology, ophthalmology, optometry and plastic surgery markets, and to more than 750 physician practices across the country.

Follow this link:

Modernizing Medicine Is Named One of the Best Places to Work by South Florida Business Journal

PITTSBURGH--(BUSINESS WIRE)--

The Center for Connected Medicine, a global thought leader defining the transformation of health care, is pleased to announce that members of its clinician panel will be delivering a presentation titled, The Tele-Tipping Point: Practicing Medicine from the Cloud, during the HIMSS 2013 Annual Conference and Exhibition. The session will take place at 9:45 a.m. CST on Wednesday, March 6.

Andrew Watson, MD, MLitt, FACS, medical director for the Center for Connected Medicine, and Rasu Shrestha, MD, MBA, vice president of medical information technology and medical director of interoperability and imaging informatics for UPMC, will discuss the movement toward patient-centric, virtual health care and the role interoperability and information systems play. As executive physicians at UPMC, Dr. Watson and Dr. Shrestha will explain how they have applied these concepts and provide results from their own experience utilizing these methods of healthcare delivery.

Drs. Watson and Shrestha bring unparalleled expertise in adapting and using technology to improve patient care. They will share a unique perspective as physicians making these concepts a reality in their daily practice of medicine, says Angela Pantelas, executive director of the Center for Connected Medicine. Session attendees will gain an understanding of what must be done in order to succeed in the evolving health care environment.

Drs. Watson and Shrestha will also assess the digital culture change in our society, and attendees will learn how it will increase adoption of virtual health care and telemedicine.

In addition to Wednesdays session, Dr. Watson and Dr. Shrestha, along with other representatives from the Center for Connected Medicine, will be giving several in-booth presentations on behalf of several of the Centers partners, including Alcatel-Lucent and Polycom. Details can be found at http://www.connectedmed.com/events.

ABOUT THE CENTER FOR CONNECTED MEDICINE

The Center for Connected Medicine is defining the transformation of health care by serving as a global thought leader. It is the worlds first collaborative health care executive briefing center dedicated to developing the blueprint for innovative patient-centered health through understanding new models of care and leveraging strategically integrated health information technology. Based in Pittsburgh, the Center opened its doors in September 2009 and is comprised of five founding partners: Alcatel-Lucent, GE Healthcare, IBM, UPMC and Verizon and eight strategic partners representing global leaders in health care. The Center draws executives and clinicians from around the world to explore the transformation of health care. Visitors experience the possibilities of an interconnected health care system firsthand, with real clinical examples, and leave the Center with new insights and methods for reinventing their organizations, streamlining their processes and embracing the new paradigm in health care. To learn more about connected medicine, as well as the Centers vision and initiatives, please visit http://www.connectedmed.com.

Link:

Center for Connected Medicine Representatives to Present During HIMSS13

Laughter is Good Medicine program open 24Feb2013
MarChasCo Productions LLC created the feature video and excerpt run of show package for the Laughter is Good medicine comedy fundraiser held at the Rialto Theatre 24Feb2013. This animation started the program. It was created using motion graphics

By: MARCHASCO

Read more here:

Laughter is Good Medicine program open 24Feb2013 - Video

Black Books: Coffee...And Some Medicine
Dylan Moran in "Black Books" (S3E1 - Manny Come Home).

By: jachymhr

See more here:

Black Books: Coffee...And Some Medicine - Video

Session 3 The veterinary landscape and perspective - Evidence Based Veterinary Medicine
Brennen McKenzie, president of the Evidence Based Veterinary Medicine Association, USA, presents "The Veterinary Landscape and Perspective" at the RCVS Charitable Trust #39;s first "Sceptical Vet: Eminence of Evidence?" symposium in London on 30 October 2012. You can read more about the symposium and download Brennen #39;s presentation at trust.rcvs.org.uk

By: RCVSCharitableTrust

View post:

Session 3 The veterinary landscape and perspective - Evidence Based Veterinary Medicine - Video

Hip Thrust Plank Cable Flyes with medicine ball push ups

By: Barbara Molyneaux

Read this article:

Hip Thrust Plank Cable Flyes with medicine ball push ups - Video

February 25, 2013 - Western Hockey League (WHL) Red Deer Rebels MEDICINE HAT - On Oscar night, Medicine Hat Tiger Curtis Valk walked down the red carpet and then took home the hardware by scoring a hat-trick in a 5-4 Tiger win over the Red Deer Rebels.

The Tiger win snapped the Rebels five-game winning streak, but they went 2-for-3 since Friday.

FIRST PERIOD

Just nine seconds in the Rebels took their first penalty over the game which led to Medicine Hat taking a 1-0 lead on Curtis Valk's goal 23 seconds later.

Red Deer tied the game 1-1 on a pinball arcade like goal at 6:09. CODY THIEL was behind the goal line when his shot went off Tiger goalie CAM LANIGAN and then in the net. RHYSE DIENO had a great chance to put the Rebels up 2-1 when he chomped on a juicy rebound, but Lanigan answered the call. The Rebels were buzzing around the Medicine Hat zone midway through the period when they had their first powerplay. But it was the Tigers who got the go ahead goal when Miles Koules scored at 10:54. The puck went off Pouliot's right shoulder and popped into the net. The Tigers took a 3-1 lead at 17:39 when Logan McVeigh scored during a BRADY GAUDET four-minute spearing penalty. Shots were 14-8 Tigers, but the big story were powerplays - the Tigers had four and cashed in on two.

SECOND PERIOD

The Rebels came out with good jump in the first few minutes. Red Deer cut the lead to 3-2 when CONNER BLEACKLEY found himself in the slot and sent a wrister into the net. Medicine Hat didn't get a shot on goal until the nine minute mark, but it was a tricky one from Zach Hodder.

The Tigers restored their two-goal lead when Volk scored his second of the game at 10:12. Volk took a nice pass from behind the net from Hunter Shinkaruk for his 40th of the season. Then, 2:24 later, Volk completed his hat-trick when he slammed in a rebound on the left side of Pouliot made it 5-2.

Red Deer seemed to be struggling a little at the end of the period, and had to defend their eighth powerplay in the final minute. The Rebels were outshot 12-10 in the middle frame and 38-13 over 60 minutes.

THIRD PERIOD

Read this article:

Rebels Edged 5-4 in Medicine Hat

Curtis Valk (left) reached the 40-goal mark on Sunday (The Canadian Press)

No. 1 star: Curtis Valk, Medicine Hat Tigers (WHL)

Valk, an undrafted 20-year-old who might have a case to be selected by a NHL team this summer, continued his superb season by scoring a hat trick in the Tigers' 5-4 win over their division rival Red Deer Rebels. Some players consider a good night to get three shots on goal against Red Deer, never mind three goals.

The 5-foot-8 forward who grew up right in Medicine Hat has been an excellent complement to highly regarded prospect Hunter Shinkaruk and has helped carry the scoring during the times when Shinkaruk has been injured. Valk (3G, +1) opened the scoring with a goal in the first minute of the game, giving the Tigers a shot of confidence. He also scored goals 3:11 apart in the second part to give the Tigers a commanding 5-2 lead. Eighteen-year-old Miles Koules also had a two-goal night for The Hat, which maintained its cushion over seventh-place Swift Current and eighth-place Kootenay in the Dub's Eastern Conference.

All told, Valk has 41 goals and 81 points this season after putting up 24 and 55 during his 18-year-old season.

No. 2 star: Sergey Tolchinsky, Sault Ste. Marie Greyhounds (OHL)

Without suspended OHL scoring leader Nick Cousins, the 'Hounds turned to another diminutive dervish of a distributor to wrap their weekend with a 4-3 come-from-behind road win at Mississauga. Tolchinsky (3A, +2) was not named a star in the arena, but the 18-year-old Muscovite made a brilliant no-look pass to Andrew Fritsch for a redirection and the winning goal with 2:35 to play.

Mississauga played reasonably well; when it went up up 3-2 in the third period, one might have expected the visiting 'Hounds to begin fading. But Tolchinsky and Fritsch, who was nmaed first star, made a great setup that led to rookie Ryan Kirkup's first OHL goal to tie the game. Overall, the 5-foot-9, 160-pound Tolchinsky has 44 points in 55 games, including eight in the Soo's last four contests. This might have been one of his best weekends of his first North American season.

No. 3 star: Alex Aleardi, Windsor Spitfires (OHL)

Aleardi delivered for the desperate Spitfires with five points in a 7-5 win over the Plymouth Whalers, his former team. The sand is running through the hourglass rapidly in southwestern Ontario. Windsor is still nine points adrift of a playoff spot with only eight games left. It could prove too little, too late, but Aleardi (2G-3A, +1) and 18-year-old Kerby Rychel (1G-2A, +1) allowed the Spitfires to trade goals with the ever-potent Plymouths, who had their seven-game win streak.

See more here:

Medicine Hat Tigers’ Curtis Valk nets hat trick in crucial win: Sunday’s 3 Stars

(PRWEB) February 25, 2013

Sports medicine is a broad branch of health care that is used by a variety of health care professionals including physical therapists, personal trainers, massage therapists, dieticians/nutritionists, chiropractors, surgeons, acupuncturists and more. While each discipline approaches sports medicine from a different angle, they all have the same goal of rehabilitating an injured athlete back to full health and mobility.

Physical therapy is a key component for any sports medicine practice. Athletes of all ages and levels get injured daily, so the Austin sports medicine physical therapists at Medicine in Motion have shared a list of five important tips to remember all day, every day - not just during exercising and sports activities.

1. Use proper techniques when lifting heavy objects to avoid hurting the back. It's a common phrase, but it bears repeating: lift with the legs. Squat to the ground and bring the item up with you, whether it weighs a lot or not. If it's too heavy to lift properly, ask for assistance.

2. Pay close attention to form, breathing and range of motion during exercises. If not performing exercises correctly, a person could do more damage than good. Dont let the mind wander during these activities make every repetition as good as it can be.

3. Always be aware of posture. Maintain an upright posture position at all times. Check out form in the mirror throughout the day if slouching, correct it. It may require a conscious effort at first, but soon it will become second nature.

4. Stretch throughout the entire day, not just before and after exercising. Take a moment at work and at home to keep the body limber.

5. Dont let nagging joint and muscle pain linger. If youre having minor pains, address it with a physical therapist. Small pains can balloon into bigger problems if theyre not dealt with.

Medicine in Motion (MIM) specializes in providing top quality sports medicine in Austin, Texas, for athletic individuals of all ages and levels. The doctors at MIM believe active bodies are healthy bodies, therefore it is the office's goal to keep patients energetic and fit. To that end, MIM provides treatment of injuries and illnesses, including the use of physical rehabilitation; promotes healthy living with personal training and nutrition coaching; and offers comprehensive sports medicine evaluations to optimize health, activity level and sports performance. For more information or for questions regarding sports medicine in Austin, contact Medicine in Motion at 512-257-2500 or visit the website at http://www.medinmotion.com.

Continue reading here:

Five Physical Therapy Tips from the Austin Sports Medicine Doctors at Medicine in Motion